IL29444A - Method for the preparation of vaccines from viruses of the influenza group - Google Patents

Method for the preparation of vaccines from viruses of the influenza group

Info

Publication number
IL29444A
IL29444A IL29444A IL2944468A IL29444A IL 29444 A IL29444 A IL 29444A IL 29444 A IL29444 A IL 29444A IL 2944468 A IL2944468 A IL 2944468A IL 29444 A IL29444 A IL 29444A
Authority
IL
Israel
Prior art keywords
virus
viruses
suspension
dialysis
concentration
Prior art date
Application number
IL29444A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL29444A publication Critical patent/IL29444A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL29444A 1967-02-21 1968-02-09 Method for the preparation of vaccines from viruses of the influenza group IL29444A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8232/67A GB1214135A (en) 1967-02-21 1967-02-21 Vaccines

Publications (1)

Publication Number Publication Date
IL29444A true IL29444A (en) 1971-12-29

Family

ID=9848505

Family Applications (1)

Application Number Title Priority Date Filing Date
IL29444A IL29444A (en) 1967-02-21 1968-02-09 Method for the preparation of vaccines from viruses of the influenza group

Country Status (9)

Country Link
US (1) US3632745A (fr)
BE (1) BE711116A (fr)
CH (1) CH540338A (fr)
DE (1) DE1667929A1 (fr)
ES (1) ES350690A1 (fr)
FR (1) FR1592089A (fr)
GB (1) GB1214135A (fr)
IL (1) IL29444A (fr)
NL (1) NL6802466A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860515A (en) * 1973-10-31 1975-01-14 Atomic Energy Commission Method for concentrating macromolecules
US3874999A (en) * 1973-10-31 1975-04-01 American Cyanamid Co Process for the purification of virus vaccine
AT406535B (de) * 1988-03-18 2000-06-26 Singerewitsch Boris Vorrichtung zur erwärmung eines strömenden mediums, insbesondere wasser
US7270990B2 (en) * 2003-06-20 2007-09-18 Microbix Biosystems, Inc. Virus production
EP1878791A1 (fr) 2006-07-11 2008-01-16 Bia Separations D.O.O. Procédé de purification de virus de la grippe

Also Published As

Publication number Publication date
GB1214135A (en) 1970-12-02
BE711116A (fr) 1968-08-21
US3632745A (en) 1972-01-04
FR1592089A (fr) 1970-05-11
DE1667929A1 (de) 1971-06-16
ES350690A1 (es) 1969-05-16
NL6802466A (fr) 1968-08-22
CH540338A (de) 1973-08-15

Similar Documents

Publication Publication Date Title
SU688124A3 (ru) Способ отделени протеинов
Wallis et al. Concentration of enteroviruses on membrane filters
EP0431129B1 (fr) Procede rendant inactifs les virus dans des compositions pharmaceutiques contaminees par des virus
EP0440483B2 (fr) Procédé de préparation d'immunoglobulines de sérum
US6267967B1 (en) Virus preparations and methods
US3874999A (en) Process for the purification of virus vaccine
NO320952B1 (no) Fremgangsmate for virusfiltrering av en losning inneholdende minst ett makromolekyl
CN105601736B (zh) 一种抗呼吸道合胞病毒人免疫球蛋白及其制备方法
US4199450A (en) Process of separating from an aqueous medium a protein or a morphologically organized unit by liquid exclusion chromatography
US4206014A (en) Process for removing detergents from virus-antigen suspensions
IL29444A (en) Method for the preparation of vaccines from viruses of the influenza group
US3316153A (en) Virus purification
EP0138167A1 (fr) Méthode de purification d'HBs antigène
US3975344A (en) Interferon purification
CN110678481B (zh) 用于纯化白蛋白的方法
AU2004249802B2 (en) Improvements in virus production
US3478145A (en) Chromatographic purification of virus with brushite modified by autoclaving
US3989818A (en) Influenza virus vaccine
RU2080124C1 (ru) Способ получения живой гриппозной вакцины
DD300833A7 (de) Verfahren zur herstellung von inaktivierten influenza-vollvirusimpfstoffen
CN104804078B (zh) 人体血清凝血因子ⅷ中的病毒过滤方法
SU1003738A3 (ru) Способ получени вакцины таежного весенне-летнего энцефалитного вируса
Schneider et al. Purification of rabies virus from tissue culture
Clark et al. Further studies on the purification of poliomyelitis virus
US3368867A (en) Chromatographic purification of influenza virus with brushite modified by autoclaving